URochester Medicine / Labs / Beck Lab / Publications

Recent Publications

1. Beck LA
2. Simpson EL
3. Thaçi D
4. de Bruin-Weller M
5. Deleuran M
6. Kataoka Y
7. Blauvelt A
8. Wollenberg A
9. Eichenfield LF
10. Khokhar FA
11. Coleman A
12. Van Spall M
13. Ma Y
14. Avetisova E
15. Zhang A
16. Nguyen TV
Long-Term Dupilumab Treatment Is Not Associated with an Increased Overall Risk of Infections in Adults with Moderate-to-Severe Atopic Dermatitis: Results from an Open-Label 5-Year Extension Study.; Advances in therapy. 2026 Apr 18.
1. Schlievert PM
2. Kilgore SH
3. Yoshida T
4. Beck LA
5. Leung DYM
Observations on emergence of mannitol-use-deficient Staphylococcus aureus.; Microbiology spectrum. 2025 Dec 19.
1. Chu X
2. Mubasher J
3. Chen L
4. Chu AWL
5. Oykhman P
6. Brignardello-Petersen R
7. Guyatt GH
8. Heen AF
9. Khan DA
10. Lang DM
11. Baker DR
12. Oliver ET
13. Sheikh J
14. Beck LA
15. Ben-Shoshan M
16. Mathur SK
17. Waserman S
18. Cole EF
19. Chan J
20. Wheeler KE
21. Trayes KP
22. Runyon L
23. Tran P
24. Asiniwasis RN
25. Gardner DD
26. Eftekhari S
27. Winders T
28. Tattrie J
29. Bernstein JA
30. Saini SS
31. Chu DK
Patient Values and Preferences in Chronic Urticaria Treatment: A Systematic Review.; JAMA dermatology. 2025 Oct 08.
1. de Bruin-Weller MS
2. Boesjes CM
3. Achten RA
4. Beck LA
5. Irvine AD
6. Vestergaard C
7. de Graaf M
8. van Wijk F
9. Bakker DS
10. Weidinger S
Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions.; Allergy. 2025 Sep 24.
1. Leshem YA
2. Weil C
3. Busse WW
4. Beck LA
5. Chodick G
6. Cyr SL
7. Bosman K
8. Lubwama R
Real-World Onset of Atopic Comorbidities Relative to Atopic Dermatitis in Pediatric Patients.; Dermatology and therapy. 2025 Sep 12.
1. Chu AWL
2. Oykhman P
3. Chu X
4. Rayner DG
5. Bhangal S
6. Dam A
7. Xu J
8. Sheikh J
9. Trayes KP
10. Frazier WT
11. Lang DM
12. Beck LA
13. Mathur SK
14. Waserman S
15. Thabane L
16. Asiniwasis RN
17. Runyon L
18. Moellman J
19. Oliver ET
20. Chan J
21. Cole EF
22. Baker DR
23. Khan DA
24. Ben-Shoshan M
25. Wheeler KE
26. Eftekhari S
27. Gardner DD
28. Winders T
29. Flindall M
30. Tattrie J
31. Bernstein JA
32. Saini SS
33. Chu DK
Comparative efficacy and safety of biologics and systemic immunomodulatory treatments for chronic urticaria: Systematic review and network meta-analysis.; The Journal of allergy and clinical immunology. 2025 Jul 11.
1. Pereira MP
2. Stevanovic K
3. Kocatürk E
4. Meesch C
5. van Hofman I
6. Vaswani PS
7. Bernstein JA
8. Bruscky D
9. Chong-Neto HJ
10. Chu CY
11. Criado RFJ
12. Ensina LF
13. Giménez-Arnau AM
14. Godse K
15. Gotua M
16. Gregoriou S
17. Kulthanan K
18. Mortz CG
19. Mitrevska NT
20. Özkaya E
21. Pudasaini P
22. Felix MMR
23. Pérez CR
24. Parisi CAS
25. Ramón GN
26. Vakirlis E
27. Zhao Z
28. Beck LA
29. de Bruin-Weller M
30. Cork M
31. Katoh N
32. Werfel T
33. Worm M
34. Wollenberg A
35. Zuberbier T
International survey of treatment practices for atopic dermatitis in pregnant and breastfeeding women: Physician perspectives.; Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 2025 Jun 08.
1. Herman KE
2. Beck LA
3. Järvinen KM
Updates to the role of diet in atopic dermatitis.; Journal of the American Academy of Dermatology. 2025 Mar 29.
1. Chinchilli E
2. Benedetto A
3. Beck LA
How We Treat Severe Atopic Dermatitis.; Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2025 Mar 13.
1. Narla S
2. Chiesa Fuxench ZC
3. Abuabara K
4. Beck LA
5. Chovatiya R
6. Thaçi D
7. Silverberg JI
What Does Long-Term Control in Atopic Dermatitis Look Like?; Dermatitis : contact, atopic, occupational, drug. 2025 Feb 10.
1. Lommatzsch M
2. Blumchen K
3. Beck LA
4. Bousquet J
5. Brusselle GG
6. Fokkens WJ
7. Hamelmann E
8. Lau S
9. Ott H
10. Pfaar O
11. Sampson HA
12. Smolen JS
13. Taube C
14. Tarner IH
15. Wagenmann M
16. Werfel T
17. Worm M
18. Renz H
Roads to remission: evolving treatment concepts in type 2 inflammatory diseases.; EClinicalMedicine; Vol 80, pp. 103050. 2025 Jan 08.
1. Kenney HM
2. Yoshida T
3. Berdyshev E
4. Calatroni A
5. Gill SR
6. Simpson EL
7. Lussier S
8. Boguniewicz M
9. Hata T
10. Chiesa Fuxench ZC
11. De Benedetto A
12. Ong PY
13. Ko J
14. Davidson W
15. David G
16. Schlievert PM
17. Leung DYM
18. Beck LA
CERS1 is a Biomarker of Staphylococcus aureus Abundance and Atopic Dermatitis Severity.; The Journal of allergy and clinical immunology. 2024 Sep 27.
1. Beck LA
2. Muraro A
3. Boguniewicz M
4. Chen Z
5. Zahn J
6. Marco AR
Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitis.; The Journal of allergy and clinical immunology. 2024 Aug 21.
1. Beck LA
2. Bissonnette R
3. Deleuran M
4. Nakahara T
5. Galus R
6. Coleman A
7. Gherardi G
8. Xiao J
9. Dingman R
10. Xu C
11. Avetisova E
12. Dubost-Brama A
13. Shabbir A
Dupilumab in Adults With Moderate to Severe Atopic Dermatitis: A 5-Year Open-Label Extension Study.; JAMA dermatology. 2024 Jul 10.
1. Peterson LF
2. Beck LA
3. Brewer MG
The mycobiome affects viral susceptibility of skin epithelium.; Journal de mycologie medicale; Vol 34(3), pp. 101499. 2024 Jul 09.
1. Mark Kenney H
2. Battaglia J
3. Herman K
4. Beck LA
Atopic Dermatitis and IgE-Mediated Food Allergy: Common Biologic Targets for Therapy and Prevention.; Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2024 Jun 20.
1. Chu AWL
2. Rayner DG
3. Chu X
4. Chen L
5. Dong AYH
6. Waserman S
7. Baker DR
8. Sheikh J
9. Moellman J
10. Lang DM
11. Ben-Shoshan M
12. Mathur SK
13. Beck LA
14. Khan DA
15. Oliver ET
16. Asiniwasis RN
17. Chan J
18. Cole EF
19. Trayes KP
20. Frazier WT
21. Runyon L
22. Wheeler KE
23. Eftekhari S
24. Gardner DD
25. Winders T
26. Bernstein JA
27. Saini SS
28. Chu DK
Topical corticosteroids for hives and itch (urticaria): systematic review and Bayesian meta-analysis of randomized trials.; Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2024 Jun 18.
1. Rayner DG
2. Liu M
3. Chu AWL
4. Chu X
5. Guyatt GH
6. Oykhman P
7. Cao DJ
8. Moellman J
9. Ben-Shoshan M
10. Baker DR
11. Waserman S
12. Lang D
13. Sheikh J
14. Mathur SK
15. Beck LA
16. Khan DA
17. Oliver ET
18. Asiniwasis RN
19. Cole EF
20. Wheeler KE
21. Runyon L
22. Chan J
23. Trayes KP
24. Eftekhari S
25. Gardner DD
26. Winders T
27. Saini SS
28. Bernstein J
29. Chu DK
Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: a systematic review and meta-analysis of randomized clinical trials.; The Journal of allergy and clinical immunology. 2024 Jun 07.
1. Chu X
2. Wang J
3. Ologundudu L
4. Brignardello-Petersen R
5. Guyatt GH
6. Oykhman P
7. Bernstein JA
8. Saini SS
9. Beck LA
10. Waserman S
11. Moellman J
12. Khan DA
13. Ben-Shoshan M
14. Baker DR
15. Oliver ET
16. Sheikh J
17. Lang D
18. Mathur SK
19. Winders T
20. Eftekhari S
21. Gardner DD
22. Runyon L
23. Asiniwasis RN
24. Cole EF
25. Chan J
26. Wheeler KE
27. Trayes KP
28. Tran P
29. Chu DK
Efficacy and Safety of Systemic Corticosteroids for Urticaria: A systematic review and meta-analysis of randomized clinical trials.; The journal of allergy and clinical immunology. In practice. 2024 Apr 18.
1. Ryan Wolf J
2. Chen A
3. Wieser J
4. Johnson B
5. Baughman L
6. Lee G
7. Pope E
8. Franco A
9. Love T
10. Beck LA
Improved patient- and caregiver-reported outcomes distinguish tacrolimus 0.03% from crisaborole in children with atopic dermatitis.; Journal of the European Academy of Dermatology and Venereology : JEADV. 2024 Feb 15.
1. Stolarczyk A
2. Perez-Nazario N
3. Knowlden SA
4. Chinchilli E
5. Grier A
6. Paller A
7. Gill SR
8. De Benedetto A
9. Yoshida T
10. Beck LA
Bleach baths enhance skin barrier, reduce itch but do not normalize skin dysbiosis in atopic dermatitis.; Archives of dermatological research. 2023 Sep 27.
1. Moran MC
2. Brewer MG
3. Schlievert PM
4. Beck LA
S. aureus virulence factors decrease epithelial barrier function and increase susceptibility to viral infection.; Microbiology spectrum. 2023 Sep 22.
1. Moran MC
2. Klose A
3. Yoshida T
4. De Benedetto A
5. Schneider LC
6. Ong PY
7. Simpson EL
8. Leung DYM
9. Miller BL
10. Seplaki CL
11. Beck LA
History of S. aureus Skin Infection Significantly Associates with History of Eczema Herpeticum in Patients with Atopic Dermatitis.; Dermatology and therapy. 2023 Aug 24.
1. Guttman-Yassky E
2. Silverberg JI
3. Thaçi D
4. Papp KA
5. Ständer S
6. Beck LA
7. Kim BS
8. Hu X
9. Liu J
10. Calimlim BM
11. Vigna N
12. Crowley JT
13. Teixeira HD
14. Thyssen JP
Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: results from a phase 2b, randomized, controlled trial.; Journal of the European Academy of Dermatology and Venereology : JEADV. 2023 Aug 01.
1. Reich K
2. Silverberg JI
3. Papp KA
4. Deleuran M
5. Katoh N
6. Strober B
7. Beck LA
8. de Bruin-Weller M
9. Werfel T
10. Zhang F
11. Biswas P
12. DiBonaventura MD
13. Chan G
14. Johnson S
15. Farooqui SA
16. Kerkmann U
17. Clibborn C
Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study.; Journal of the European Academy of Dermatology and Venereology : JEADV. 2023 Jun 19.
1. Reich K
2. Silverberg JI
3. Papp KA
4. Deleuran M
5. Katoh N
6. Strober B
7. Beck LA
8. de Bruin-Weller M
9. Werfel T
10. Zhang F
11. Biswas P
12. DiBonaventura MD
13. Chan G
14. Farooqui SA
15. Kerkmann U
16. Clibborn C
Abrocitinib effect on patient-reported outcomes in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study.; Journal of the European Academy of Dermatology and Venereology : JEADV. 2023 Jun 15.
1. Simpson EL
2. Schlievert PM
3. Yoshida T
4. Lussier S
5. Boguniewicz M
6. Hata T
7. Fuxench Z
8. De Benedetto A
9. Ong PY
10. Ko J
11. Calatroni A
12. Rudman Spergel AK
13. Plaut M
14. Quataert SA
15. Kilgore SH
16. Peterson L
17. Gill AL
18. David G
19. Mosmann T
20. Gill SR
21. Leung DYM
22. Beck LA
Rapid Reduction in Staphylococcus aureus in Atopic Dermatitis Subjects Following Dupilumab Treatment.; The Journal of allergy and clinical immunology. 2023 Jun 12.
1. Guttman-Yassky E
2. Bahadori L
3. Brooks L
4. Clark KL
5. Grindebacke H
6. Ho CN
7. Katial R
8. Pham TH
9. Walton C
10. Datto CJ
Lack of effect of benralizumab on signs and symptoms of moderate-to-severe atopic dermatitis: Results from the phase 2 randomized, double-blind, placebo-controlled HILLIER trial.; Journal of the European Academy of Dermatology and Venereology : JEADV; Vol 37(10), pp. e1211-e1214. 2023 Jun 12.
1. Arnold KA
2. Peterson LF
3. Beck LA
4. Brewer MG
JAK Signaling Is Critically Important in Cytokine-Induced Viral Susceptibility of Keratinocytes.; International journal of molecular sciences; Vol 24(11). 2023 May 25.
1. Simpson EL
2. De Benedetto A
3. Boguniewicz M
4. Ong PY
5. Lussier S
6. Villarreal M
7. Schneider LC
8. Paller AS
9. Guttman-Yassky E
10. Hanifin JM
11. Spergel JM
12. Barnes KC
13. David G
14. Austin B
15. Leung DYM
16. Beck LA
Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity from the ADRN Registry.; The journal of allergy and clinical immunology. In practice. 2023 May 12.
1. Moran MC
2. Chinchilli E
3. Kenney HM
4. Pope EM
5. Scott G
6. Brewer MG
7. Beck LA
Stage of Keratinocyte Differentiation is a Key Determinant of Viral Susceptibility in Human Skin.; The Journal of investigative dermatology. 2023 Mar 28.
1. Zuberbier T
2. Beck LA
3. Bedbrook A
4. de Bruin-Weller M
5. Bousquet J
6. Cork M
7. Douladiris N
8. Katoh N
9. Mortz CG
10. Werfel T
11. Wojciech F
12. Wollenberg A
13. Siemens K
14. Stevanovic K
15. Worm M
Developing integrated care pathways for atopic dermatitis-Challenges and unmet needs.; Clinical and translational allergy; Vol 13(3), pp. e12236. 2023 Mar.
1. Smith HD
2. Williams B
3. Beck LA
4. De Benedetto A
Erythema Multiforme Secondary to Poison Ivy Contact Dermatitis.; Dermatitis : contact, atopic, occupational, drug. 2023 Feb 27.
1. Yang B
2. Wilkie H
3. Das M
4. Timilshina M
5. Bainter W
6. Woods B
7. Daya M
8. Boorgula MP
9. Mathias RA
10. Lai P
11. Petty CR
12. Weller E
13. Harb H
14. Leung DYM
15. Beck LA
16. Simpson EL
17. Hata TR
18. Barnes KC
19. Phipatanakul W
20. Leyva-Castillo JM
21. Geha RS
The IL-4Rα Q576R polymorphism is associated with increased severity of atopic dermatitis and exaggerates allergic skin inflammation in mice.; The Journal of allergy and clinical immunology. 2023 Jan 20.
1. Bissonnette R
2. Simpson E
3. Eichenfield LF
4. Guttman-Yassky E
5. Silverberg JI
6. Beck LA
7. Mija L
8. Thyssen JP
9. Bieber T
10. Kabashima K
11. Siegfried E
12. Stingl G
13. van de Kerkhof P
14. Yosipovitch G
15. Paul C
16. Paller AS
The vIGA-AD scale for atopic dermatitis: uptake in the past five years and position of the International Eczema Council.; Journal of the European Academy of Dermatology and Venereology : JEADV. 2023 Jan 09.
1. Schlievert PM
2. Kilgore SH
3. Beck LA
4. Yoshida T
5. Klingelhutz AJ
6. Leung DYM
Host Cationic Antimicrobial Molecules Inhibit S. aureus Exotoxin Production.; mSphere. 2023 Jan 04.
1. Moran MC
2. Pope EM
3. Brewer MG
4. Beck LA
Supply Chain Disruptions During COVID Pandemic Uncover Differences in Keratinocyte Culture Media.; JID innovations : skin science from molecules to population health. 2022 Aug 22.
1. Paller AS
2. Beck LA
Bleach baths for atopic dermatitis: Evidence of efficacy but more data are needed.; Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology; Vol 128(6). 2022 Jun.
1. Beck LA
2. Deleuran M
3. Bissonnette R
4. de Bruin-Weller M
5. Galus R
6. Nakahara T
7. Seo SJ
8. Khokhar FA
9. Vakil J
10. Xiao J
11. Marco AR
12. Levit NA
13. O'Malley JT
14. Shabbir A
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.; American journal of clinical dermatology. 2022 May 03.
1. Beck LA
2. Cork MJ
3. Amagai M
4. De Benedetto A
5. Kabashima K
6. Hamilton JD
7. Rossi AB
Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis.; JID innovations : skin science from molecules to population health; Vol 2(5), pp. 100131. 2022 Apr 26.
1. Brewer MG
2. Monticelli SR
3. Moran MC
4. Miller BL
5. Beck LA
6. Ward BM
Conditions That Simulate the Environment of Atopic Dermatitis Enhance Susceptibility of Human Keratinocytes to Vaccinia Virus.; Cells; Vol 11(8). 2022 Apr 14.
1. Pope EM
2. Laageide L
3. Beck LA
Management of Allergic Skin Disorders in Pregnancy.; Immunology and allergy clinics of North America; Vol 43(1), pp. 117-132. 2022 Jan 28.
1. Paller AS
2. Beck LA
3. Blauvelt A
4. Siegfried EC
5. Cork MJ
6. Wollenberg A
7. Chen Z
8. Khokhar FA
9. Vakil J
10. Zhang A
11. Bansal A
12. Cyr SL
Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data.; Pediatric dermatology. 2022 Jan 26.
1. Beck LA
2. Pesonen M
3. Thakar J
4. Georas SN
5. Järvinen KM
IgE Sensitization Drives the Atopic March.; American journal of respiratory and critical care medicine. 2022 Jan 08.
1. Beck LA
2. Bieber T
3. Weidinger S
4. Tauber M
5. Saeki H
6. Irvine AD
7. Eichenfield LF
8. Werfel T
9. Arlert P
10. Jiang L
11. Røpke M
12. Paller AS
Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: analysis of microbial diversity in ECZTRA 1, a randomized controlled trial.; Journal of the American Academy of Dermatology. 2022 Jan 03.
1. Herman KE
2. Yoshida T
3. Hughson A
4. Grier A
5. Gill SR
6. Beck LA
7. Fowell DJ
IL-17-Dependent Dysregulated Cutaneous Immune Homeostasis in the Absence of the Wiskott-Aldrich Syndrome Protein.; Frontiers in immunology; Vol 13. 2022.
1. Yoshida T
2. Beck LA
3. De Benedetto A
Skin barrier defects in atopic dermatitis: From old idea to new opportunity.; Allergology international : official journal of the Japanese Society of Allergology. 2021 Dec 13.
1. Tuttle KL
2. Forman J
3. Beck LA
Novel systemic treatments in atopic dermatitis: Are there sex differences?; International journal of women's dermatology; Vol 7(5Part A). 2021 Dec.
1. Wollenberg A
2. Beck LA
3. de Bruin Weller M
4. Simpson EL
5. Imafuku S
6. Boguniewicz M
7. Zachariae R
8. Olsen CK
9. Thyssen JP
Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trials.; The British journal of dermatology. 2021 Oct 12.
1. Daya M
2. Cox C
3. Acevedo N
4. Boorgula MP
5. Campbell M
6. Chavan S
7. Cho MH
8. David GL
9. Kachroo P
10. Lasky-Su J
11. Li X
12. McHugh CP
13. Qiao D
14. Rafaels N
15. Beck LA
16. Bleecker ER
17. Caraballo L
18. Cupples AL
19. Figueiredo CA
20. Gallo RL
21. Hanifin J
22. Hansel NN
23. Hata TR
24. Hersh CP
25. Knight-Madden J
26. Leung DYM
27. Guttman-Yassky E
28. Meyers DA
29. O'Connor G
30. Ober C
31. Ong PY
32. Ortega VE
33. Paller AS
34. Putcha N
35. Reed RM
36. Schneider LC
37. Silverman EK
38. Slifka MK
39. Spergel JM
40. Vasan RS
41. Viaud-Martinez KA
42. Watson H
43. Weiss ST
44. Ruczinski I
45. Beaty TH
46. Mathias RA
47. Barnes KC
Multi-ethnic genome-wide and HLA association study of total serum IgE.; The Journal of allergy and clinical immunology. 2021 Sep 15.